New tech aims to sharpen precision of liver cancer treatments
NCT ID NCT05582018
Summary
This study tested a computer system called BioTraceIO 360 designed to help doctors plan, monitor, and check liver tumor ablation procedures. Ablation uses heat to destroy cancer cells. The tool aimed to give doctors better guidance on where to place the treatment probe and more confidence during the procedure. The small pilot study was terminated early after enrolling only 4 of a planned 30 patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Einstein Medical Center
Philadelphia, Pennsylvania, 19141, United States
Conditions
Explore the condition pages connected to this study.